Alvotech (ALVO) vs Harmony Biosciences Holdings, Inc. (HRMY)

A side-by-side comparison of Alvotech and Harmony Biosciences Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALVO vs HRMY

growth of $100 · dividends reinvested · last 4y
ALVO -45.4% (-14.0%/yr)HRMY -6.0% (-1.5%/yr)HRMY compounded faster over this window
50100150Start $1002023202420252026$55$94
ALVO HRMY

ALVO vs HRMY: by the numbers

  • •HRMY is the larger company ($2.31B vs $2.06B market cap).
  • •HRMY is profitable (18.88% net margin) while ALVO runs a net loss (-36.51%).
  • •ALVO grew revenue faster over the past five years (69.03% vs 32.47% CAGR).

Metrics side by side

Valuation

MetricALVOHRMY
P/E ratioN/A12.98
Forward P/EN/A10.14
P/S ratio4.192.41
P/B ratioN/A2.32
EV / EBITDA41.787.50
FCF yieldN/A15.33%

Profitability

MetricALVOHRMY
Gross margin60.45%75.42%
Operating margin9.62%24.03%
Net margin-36.51%18.88%
ROEN/A18.14%
ROIC3.61%14.96%

Growth (annualized)

MetricALVOHRMY
Revenue CAGR (5Y)69.03%32.47%
FCF CAGR (5Y)N/A48.43%
Total return CAGR (5Y)N/A0.91%

Frequently asked

Which has grown faster, ALVO or HRMY?
Over the past five years, ALVO grew revenue faster — ALVO at a 69.03% CAGR versus HRMY at 32.47%.
Is ALVO or HRMY more profitable?
HRMY runs the higher net margin — ALVO at -36.51% versus HRMY at 18.88%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.